We use cookies for a better user experience. Read our Privacy Policy

I Agree

Cancer Cachexia Market Trends, 2017-2025

Cancer Cachexia Market (Therapeutics - Progestogens and Corticosteroids Combination Therapies; Mechanism of Action - Appetite Stimulators and Weight Loss Stabilizers; Distribution channels - Hospital Stores, Retail Pharmacy Stores, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Cancer Cachexia Market – Overview

An expansion in the prevalence of serious health conditions, for example, cancer and the rising number of cachexia among this patient pool is assessed to fuel the business possibilities in the worldwide cancer cachexia market in the impending years. Cachexia alludes to an intricate syndrome connected to an essential illness that can prompt muscle misfortune, which can't be switched totally by giving nourishing supplementation to a body.

The worldwide market for cancer cachexia market is presently in the sprouting stage. On the grounds of a promising clinical pipeline and approaching regulatory endorsements, this market is relied upon to observe extraordinary ascent throughout the next few years. The neglected requirement for the therapy of cancer cachexia in creating economies is likewise expected to drive the development of this market during the forecast period.

The cancer cachexia market will build up significant speed from the developing mindfulness about working on the existence of cancer patients. Analysts have been looking for pharmacological medicines utilizing different substance compounds, thereby indicating that the non-steroidal calming drugs (NSAIDs) have shown great guarantee.

The improvement of the overall cancer cachexia market is filled by an enormous assessment on using different experts for treating metabolic inconsistencies in cachexia. Headway of these different pharmacologic experts will furthermore collect steam on the back of the regulatory scene. The growing load of cancers generally speaking moreover fabricates the inescapability of cancer cachexia among patients suffering from cancer, depicted by basic bothering, negative protein and energy balance, and a mandatory loss of fit weight.

Continuous clinical trials in oncology depict insights into the multifactorial pathogenicity of the syndrome cancer cachexia. Understanding the cancer cachexia instrument has become basic for the comprehension of prognostic variables for cancer. Biopharmaceuticals looking for a fortification in the worldwide cancer cachexia market have taken on systems that speed up an ideal opportunity to-market of novel drug specialists.

The cancer cachexia market is projected to rise at a CAGR of 4.90% and rise from a value of US$1.63 bn earned in 2016 to US$ 2.51 bn by the end of 2025.

cancer-cachexia-market.jpg

Progestogens Section Holding Dominance in Market Segment as per Therapeutics

The global cancer cachexia market is classified on the basis of therapeutics, mechanism of action, distribution channel, and regions. In terms of therapeutics, the market is grouped into progestogens, corticosteroids, combination therapies, and others. Among these, progestogens are viewed as the best accessible therapy choice for cancer-related cachexia across the world. The notoriety of progestogens is to such an extent that these are the main medications endorsed in Europe for the therapy of cancer cachexia. This medication fragment is relied upon to stay on the top throughout the approaching years.

Based on mechanism of action, the market is trifurcated into weight loss stabilizers, appetite stimulators, and others. Further classification of distribution channel includes online pharmacy, retail pharmacy stores, and hospital stores.

North America to dominate market with Asia Pacific in close competition

In terms of regional segmentation, the lion's share is earned by North America. An enormous piece of the development force comes from propelling worldview of care for cancer patients. Further, the prevalence of cachexia in Japan and Europe will make these key cancer cachexia markets in the forecast period. This provincial market is projected to stay driving soon, on account of the expanding mindfulness among individuals and healthcare experts about cancer's steady consideration. Aside from this, the presence of pipeline drugs in stage 3 clinical preliminary, which will be carried out in the market throughout the following 2-3 years, is likewise expected to drive the market for cancer cachexia in North America sooner rather than later. Europe, which has been following North America intently, is anticipated to surface as a more worthwhile market for cancer cachexia throughout the impending years, inferable from the proceeded with the training of offering limits on drugs, explicitly utilized for the therapy of cancer, by companies manufacturing in this region.

This local market is projected to stay driving soon, on account of the expanding mindfulness among individuals and healthcare experts about cancer steady consideration. Aside from this, the presence of pipeline drugs in stage 3 clinical preliminary, which will be carried out in the market over the course of the following 2-3 years, is additionally expected to drive the market for cancer cachexia in North America sooner rather than later. Europe, which has been following North America intently, is anticipated to surface as a more worthwhile market for cancer cachexia throughout the approaching years, attributable to the proceeded with training of offering limits on drugs, explicitly utilized for the therapy of cancer, by makers around here.

Additionally, Asia Pacific is likewise projected to report appealing freedoms for the development of the overall market for cancer cachexia market in the years to come. The cancer cachexia market in the Asia Pacific is relied upon to enlist a fundamentally high-paced development soon, because of the presence of an enormous pool of undiscovered patients, quick urbanization, ascend in discretionary cashflow, expanding government support for healthcare, and the increasing mindfulness about cancer cachexia among individuals here.

Considering the projected growth metabolizers and the estimated CAGRs that the cancer cachexia market may exhibit in the coming years, the competitive nature of this global market is highly fragmented. The presence of multiple players and their intense investment on research and development technologies are likely to help intensify the overall market competition.

The global cancer cachexia market has been segmented as follows:

Therapeutics

  • Progestogens
  • Corticosteroids
  • Combination Therapies
  • Others

Mechanism of action

  • Appetite Stimulators
  • Weight Loss Stabilizers
  • Others

Distribution Channel

  • Hospital Stores
  • Retail Pharmacy Stores
  • Online Pharmacy

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of MEA
Cancer Cachexia Market Trends, 2017-2025

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of cancer cachexia market?

The global cancer cachexia market was worth US$1.63 bn and is projected to reach a value of US$ 2.51 bn by the end of 2025

What is the anticipated CAGR of the cancer cachexia market in the forecast period?

Cancer cachexia market is anticipated to grow at a CAGR of 4.9% during the forecast period

Which region is expected to project the highest market share in the global cancer cachexia market?

North America accounted for a major share of the global cancer cachexia market

What are the key driving factors for the growth of the cancer cachexia market?

Cancer cachexia market expansion in the prevalence of serious health conditions and cancer and the rising number of cachexia among this patient pool

Who are the key players in the global cancer cachexia market?

Key players in the global cancer cachexia market include Novartis, Merck & Co. Inc., Eli Lilly and Co., Aphios Corp., Alder BioPharmaceuticals Inc., and Aeterna Zentaris.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Cachexia Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Therapeutics Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
     4.5. Global Cancer Cachexia Market Analysis and Forecasts, 2014-2024
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Cancer Cachexia Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Regulatory Scenario
     4.9. Cancer Cachexia – Incidence Rate
     4.10. Cancer Cachexia – Therapeutic Approach
     4.11. Cancer Cachexia Market: Pipeline Analysis
            4.11.1. Phase III drugs (Forecast from approval year to 2024)
            4.11.2. Phase I and Phase II drugs (Qualitative Information)

5. Global Cancer Cachexia Market Analysis and Forecasts, By Therapeutics 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast by Therapeutics, 2015–2025
            5.4.1. Progestogens
            5.4.2. Corticosteroids
            5.4.3. Combination therapies
     5.5. Market Attractiveness by Therapeutics
 
6. Global Cancer Cachexia Market Analysis and Forecasts, By Mechanism of action 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast by Mechanism of action, 2015–2025
            6.4.1. Appetite Stimulators
            6.4.2. Weight loss stabilizers
            6.4.3. Others
     6.5. Market Attractiveness by Mechanism of action 

7. Global Cancer Cachexia Market Analysis and Forecasts, By Distribution Channels 
     7.1. Introduction & Definition
     7.3. Key Trends
     7.4. Market Value Forecast by Distribution Channels, 2015–2025
            7.4.1. Hospital Stores
            7.4.2. Retails Pharmacy Store
            7.4.3. Online Pharmacy
     7.5. Market Attractiveness by Distribution Channels 

8. Global Cancer Cachexia Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast by Region
            8.3.1. North America 
            8.3.2. Europe 
            8.3.3. Asia Pacific 
            8.3.4. Latin America 
            8.3.5. Middle East and Africa
     8.4. Market Attractiveness by Country/Region

9. North America Cancer Cachexia Market Analysis and Forecast
     9.1. Introduction
            9.1.2. Policies and Regulations
            9.1.3. Key Trends
     9.2. Market Value Forecast by Therapeutics, 2015–2025
            9.2.1. Progestogens
            9.2.2. Corticosteroids
            9.2.3. Combination therapies
     9.3. Market Value Forecast by Mechanism of action, 2015–2025
            9.3.1. Appetite Stimulators
            9.3.2. Weight loss stabilizers
            9.3.3. Others
     9.4. Market Value Forecast by Distribution Channels, 
            9.4.1. Hospital Stores
            9.4.2. Retails Pharmacy Store
            9.4.3. Online Pharmacy
     9.5. Market Value Forecast by Country, 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Therapeutics 
            9.6.2. By Mechanism of action 
            9.6.3. By Distribution Channels 
            9.6.4. By Country

10. Europe Cancer Cachexia Market Analysis and Forecast
     10.1. Introduction
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2. Market Value Forecast by Therapeutics, 2015–2025
            10.2.1. Progestogens
            10.2.2. Corticosteroids
            10.2.3. Combination therapies
     10.3. Market Value Forecast by Mechanism of action, 2015–2025
            10.3.1. Appetite Stimulators
            10.3.2. Weight loss stabilizers
            10.3.3. Others
     10.4. Market Value Forecast by Distribution Channels, 
            10.4.1. Hospital Stores
            10.4.2. Retails Pharmacy Store
            10.4.3. Online Pharmacy
     10.5. Market Value Forecast by Country, 2015–2025
            10.5.1. U.K.
            10.5.2. Germany
            10.5.3. France
            10.5.4. Italy
            10.5.5. Spain
            10.5.6. Russia
            10.5.7. Rest of Europe
     10.6. Market Attractiveness Analysis 
            10.6.1. By Therapeutics 
            10.6.2. By Mechanism of action 
            10.6.3. By Distribution Channels 
            10.6.4. By Country

11. Asia-Pacific Cancer Cachexia Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Policies and Regulations
            11.1.2. Key Trends
     11.2. Market Value Forecast by Therapeutics, 2015–2025
            11.2.1. Progestogens
            11.2.2. Corticosteroids
            11.2.3. Combination therapies
     11.3. Market Value Forecast by Mechanism of action, 2015–2025
            11.3.1. Appetite Stimulators
            11.3.2. Weight loss stabilizers
            11.3.3. Others
     11.4. Market Value Forecast by Distribution Channels, 
            11.4.1. Hospital Stores
            11.4.2. Retails Pharmacy Store
            11.4.3. Online Pharmacy
     11.5. Market Value Forecast by Country, 2015–2025
            11.5.1. India
            11.5.2. China
            11.5.3. Japan
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia-Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Therapeutics 
            11.6.2. By Mechanism of action 
            11.6.3. By Distribution Channels 
            11.6.4. By Country

12. Latin America Cancer Cachexia Market Analysis and Forecast
     12.1. Introduction
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2. Market Value Forecast by Therapeutics, 2015–2025
            12.2.1. Progestogens
            12.2.2. Corticosteroids
            12.2.3. Combination therapies
     12.3. Market Value Forecast by Mechanism of action, 2015–2025
            12.3.1. Appetite Stimulators
            12.3.2. Weight loss stabilizers
            12.3.3. Others
     12.4. Market Value Forecast by Distribution Channels, 
            12.4.1. Hospital Stores
            12.4.2. Retails Pharmacy Store
            12.4.3. Online Pharmacy
     12.5. Market Value Forecast by Country, 2015–2025
            12.5.1. Brazil
            12.5.2. Mexico
            12.5.3. Rest of Latin America
     12.6. Market Attractiveness Analysis 
            12.6.1. By Therapeutics 
            12.6.2. By Mechanism of action 
            12.6.3. By Distribution Channels 
            12.6.4. By Country

13. Middle East and Africa Cancer Cachexia Market Analysis and Forecast
     13.1. Introduction
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2. Market Value Forecast by Therapeutics, 2015–2025
            13.2.1. Progestogens
            13.2.2. Corticosteroids
            13.2.3. Combination therapies
            13.2.4. Others
     13.3. Market Value Forecast by Mechanism of action, 2015–2025
            13.3.1. Appetite Stimulators
            13.3.2. Weight loss stabilizers
            13.3.3. Others
     13.4. Market Value Forecast by Distribution Channels, 
            13.4.1. Hospital Stores
            13.4.2. Retails Pharmacy Store
            13.4.3. Online Pharmacy
     13.5. Market Value Forecast by Country, 2015–2025
            13.5.1. South Africa
            13.5.2. GCC Countries
            13.5.3. Rest of Middle East and Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Therapeutics 
            13.6.2. By Mechanism of action 
            13.6.3. By Distribution Channels 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Competition Analysis by Company (2016)
     14.2. Company Profiles
            14.2.1. Æterna Zentaris Inc.
                      14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.1.2. Financials
                      14.2.1.3. Recent Development
                      14.2.1.4. Strategy
            14.2.2. Alder BioPharmaceuticals Inc.
                      14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.2.2. Financials
                      14.2.2.3. Recent Development
                      14.2.2.4. Strategy
            14.2.3. Aphios Corporation
                      14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.3.2. Financials
                      14.2.3.3. Recent Development
                      14.2.3.4. Strategy
            14.2.4. Eli Lilly and Company
                      14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.4.2. Financials
                      14.2.4.3. Recent Development
                      14.2.4.4. Strategy
            14.2.5. GTx, Inc.
                      14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.5.2. Financials
                      14.2.5.3. Recent Development
                      14.2.5.4. Strategy
            14.2.6. Helsinn Group
                      14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.6.2. Financials
                      14.2.6.3. Recent Development
                      14.2.6.4. Strategy
            14.2.7. Merck & Co., Inc.
                      14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.7.2. Financials
                      14.2.7.3. Recent Development
                      14.2.7.4. Strategy
            14.2.8. Novartis AG
                      14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.8.2. Financials
                      14.2.8.3. Recent Development
                      14.2.8.4. Strategy
            14.2.9. Bristol-Myers Squibb Company
                      14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.9.2. Financials
                      14.2.9.3. Recent Development
                      14.2.9.4. Strategy
            14.2.10. XBiotech, Inc.
                      14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.10.2. Financials
                      14.2.10.3. Recent Development
                      14.2.10.4. Strategy

List of Tables

Table 01: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 02: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 03: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 04: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 07: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 08: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 09: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 11: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 12: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 15: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 16: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 17: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 19: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 20: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 21: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 23: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 24: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Figures

Figure 01: Global Progestogens Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 02: Global Corticosteroids Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 03: Global Combination Therapies Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 04: Global Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2015–2025
Figure 05: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Therapeutics, 2016 and 2025
Figure 06: Global Appetite Stimulators Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 07: Global Weight Loss Stabilizers Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 08: Global Others Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 09: Global Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2015–2025
Figure 10: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 11: Global Hospital Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 12: Global Retail Pharmacy Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 13: Global Online Pharmacy Value Market (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 14: Global Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2015–2025
Figure 15: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2016 and 2025
Figure 16: Global Cancer Cachexia Market Value Share Analysis, by Region, 2016 and 2025
Figure 17: Global Cancer Cachexia Market Attractiveness Analysis, by Region
Figure 18: North America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 19: North America Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 20: North America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 21: North America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 22: North America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 23: North America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 24: North America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 25: North America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 26: North America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 27: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 28: Europe Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 29: Europe Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 30: Europe Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 31: Europe Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 32: Europe Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 33: Europe Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 34: Europe Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 35: Europe Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 36: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 37: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 38: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 40: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 41: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 42: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 43: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 44: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 45: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 46: Latin America Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 47: Latin America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 48: Latin America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 49: Latin America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 50: Latin America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Latin America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 52: Latin America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 53: Latin America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 54: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 55: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 56: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 57: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 58: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 59: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 60: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 61: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 62: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 63: Æterna Zentaris, Inc., Net Sales, by Region, 2016
Figure 64: Æterna Zentaris, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 65: Æterna Zentaris, Inc., Breakdown of Net Sales, by Product, 2016
Figure 66: Æterna Zentaris, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
Figure 67: Alder BioPharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2014, 2016
Figure 68: Alder BioPharmaceuticals, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
Figure 69: Eli Lilly and Company, Net Sales, by Region, 2016
Figure 70: Eli Lilly and Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 71: Eli Lilly and Company, Breakdown of Net Sales, by Business Segment, 2016
Figure 72: Eli Lilly and Company, Research and Development Cost, 2016 and 2015 (US$ Mn)
Figure 73: Merck & Co., Inc., Net Sales, by Region, 2016
Figure 74: Merck & Co., Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 75: Merck & Co., Inc., Breakdown of Net Sales, by Business segment, 2016
Figure 76: Merck & Co., Inc., Research and Development Cost, 2016 and 2015 (US$ Bn)
Figure 77: Novartis AG, Net Sales, by Region, 2016
Figure 78: Novartis AG, Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 79: Novartis AG, Breakdown of Net Sales, by Business segment, 2016
Figure 80: Novartis AG, Breakdown of Net Sales, by Business Units, 2016
Figure 81: Bristol-Myers Squibb Company, Net Sales, by Region, 2016
Figure 82: Bristol-Myers Squibb Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 83: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Business segment, 2016
Figure 84: Bristol-Myers Squibb Company, Research and Development Cost, 2016 and 2015 (US$ Mn)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

346

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved